DB
David M Berman
Head of R&D

David M Berman insider trades: Immunocore Holdings (IMCR) stock sales

Head of R&D, Immunocore Holdings Last trade Feb 18, 2026 11 Form 4 filings
$5.2M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2024
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 18, 2026IMCR↓ Sell$193K
Dec 5, 2025IMCR↓ Sell$1.3M
Nov 28, 2025IMCR↓ Sell$3.0M
Nov 25, 2025IMCR↓ Sell$725K
Sep 30, 2025IMCR↓ Sell$2.2M
Sep 15, 2025IMCR↓ Sell$811K
Sep 11, 2025IMCR↓ Sell$1.8M
Feb 28, 2024IMCR↓ Sell$2.5M
Feb 27, 2024IMCR↓ Sell$5.9M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IMCR insiders

Open-market trades in the last 12 months

About David M Berman's insider trades

David M Berman is Head of R&D at Immunocore Holdings (IMCR). Since Feb 27, 2024, David has reported no open-market purchases and 9 sales worth $18.4M on SEC Form 4. In the last 12 months: 4 sales ($5.2M).

Their filings also include option exercises (9 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.